BAUM MARK L Insider Trading Activity

Average Profitability
19.45%
Insider Buys Quantity
7
Insider Buys Sum
$957,788.00
Insider Sells Quantity
1
Insider Sells Sum
$437,979.41

Insider Activity of BAUM MARK L

According to the SEC Form 4 filings, BAUM MARK L, being in a position of

  1. CHIEF EXECUTIVE OFFICER at Harrow Health, Inc.,
    оver the last 12 months, has bought 10000 shares for $302,000, and sold 0 shares,
    over all time since 2016-12-19, has bought 213300 shares for $1.18M, and sold 0 shares.

Biography of BAUM MARK L

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $302,0001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-05-14PurchaseHarrow Health, Inc.
HROW
CHIEF EXECUTIVE OFFICER
10,000
0.0263%
$30.20$302,000+20.77%
2024-03-22PurchaseHarrow Health, Inc.
HROW
CHIEF EXECUTIVE OFFICER
9,000
0.0256%
$11.59$104,310+169.65%
2023-11-16PurchaseHarrow Health, Inc.
HROW
Chief Executive Officer
7,500
0.0201%
$8.11$60,825+94.88%
2023-08-14PurchaseHarrow Health, Inc.
HROW
Chief Executive Officer
5,800
0.0168%
$17.05$98,890-23.5%
2022-12-22PurchaseHarrow Health, Inc.
HROW
Chief Executive Officer
25,000
0.0941%
$13.39$334,750+27.43%
2018-11-15PurchaseEton Pharmaceuticals, Inc.
ETON
director
10,000
0.1545%
$6.00$60,000+7.11%
2017-03-03PurchaseIdeal Power Inc.
IPWR
director
7,800
0.0704%
$2.54$19,773-11.24%
2016-12-19PurchaseHarrow Health, Inc.
HROW
Chief Executive Officer
156,000
0.8578%
$1.79$279,240+43.9%
2015-11-13SaleIdeal Power Inc.
IPWR
director
58,126
0.6387%
$7.54$437,979-30.67%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.